Skip to main content
Year archive

PERCHERON THERAPEUTICS LIMITED — 2003 filings

All 33 regulatory filings released by PERCHERON THERAPEUTICS LIMITED (PER) in 2003, sourced directly from the official regulator.

33 Filings
2003 Period
2003 filings (33)
Filing Released Lang
Change of Director's Interest Notice 3 pages ?Kb
Director's Dealing
2003-12-23 English
Appendix 3B - End of Restriction Period 9 pages ?Kb
Regulatory Filings
2003-12-21 English
Updated Corporate presentation 10 pages ?Kb
Regulatory Filings
2003-12-15 English
Investor Update 3 pages ?Kb
Regulatory Filings
2003-12-08 English
Securities to be released from escrow 1 page ?Kb
Regulatory Filings
2003-12-04 English
Appendix 3B - Funds Applied to Drug Development Projects 9 pages ?Kb
Capital/Financing Update
2003-11-06 English
AGM 2003 - Presentation 4 pages ?Kb
AGM Information
2003-10-30 English
Results of Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2003-10-30 English
Commitments Test Entity - First Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2003-10-19 English
Cash Reserves of $15.4 million - no borrowings 2 pages ?Kb
Capital/Financing Update
2003-10-19 English
Change of Director's Interest Notice x 2 5 pages ?Kb
Regulatory Filings
2003-10-13 English
Appendix 3B - SPP/Exercise of Options 10 pages ?Kb
Regulatory Filings
2003-10-07 English
Annual Report/Notice of AGM 55 pages ?Kb
Regulatory Filings
2003-09-25 English
Appendix 3B - Exercise of Options 9 pages ?Kb
Regulatory Filings
2003-09-21 English
Letter to Shareholders re Share Purchase Plan 5 pages ?Kb
Regulatory Filings
2003-09-01 English
Investor Update-Initiation of Phase 1 Study for MS Drug 4 pages ?Kb
Regulatory Filings
2003-08-26 English
Appendix 3B - Issue to Fund Drug Development Projects 10 pages ?Kb
Regulatory Filings
2003-08-21 English
Preliminary Final Report/Full Year Accounts 36 pages ?Kb
Regulatory Filings
2003-08-21 English
Trading Halt 1 page ?Kb
Regulatory Filings
2003-08-17 English
Updated Corporate Presentation 18 pages ?Kb
Regulatory Filings
2003-08-12 English
Commitments Test Entity - Fourth Quarter Report 5 pages ?Kb
Regulatory Filings
2003-07-30 English
To initiate Proof of Concept Study for Psoriasis Proj 2 pages ?Kb
Regulatory Filings
2003-07-23 English
Presentation - Boston Bio-Relationships Conference 18 pages ?Kb
Investor Presentation
2003-06-16 English
Appendix 3B - Exercise of options to purchase shares 9 pages ?Kb
Capital/Financing Update
2003-06-12 English
Psoriasis Therapy Achieves Important Milestone 2 pages ?Kb
Regulatory Filings
2003-06-04 English
$1.1million R&D Grant Approved for Psoriasis Project 2 pages ?Kb
Regulatory Filings
2003-05-18 English
Commitments Test Entity - Third Quarter Report 5 pages ?Kb
Regulatory Filings
2003-04-27 English
Presentation 18 pages ?Kb
Investor Presentation
2003-03-27 English
Half Year Accounts 13 pages ?Kb
Interim / Quarterly Report
2003-03-05 English
Investor Update 5 pages ?Kb
Regulatory Filings
2003-02-13 English
Half Yearly Report 27 pages ?Kb
Interim / Quarterly Report
2003-02-06 English
Approval for Human Trials to Commence on new MS Treatment 2 pages ?Kb
Regulatory Filings
2003-02-03 English
Commitments Test Entity - Second Quarter Report 6 pages ?Kb
Interim / Quarterly Report
2003-01-30 English